- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/94 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
Patent holdings for IPC class C07D 307/94
Total number of patents in this class: 255
10-year publication summary
|
20
|
23
|
27
|
17
|
19
|
12
|
15
|
10
|
17
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Autifony Therapeutics Limited | 48 |
22 |
| Daiichi Sankyo Company, Limited | 1869 |
17 |
| SFC Co., Ltd. | 321 |
12 |
| Temple University of the Commonwealth System of Higher Education | 615 |
12 |
| Merck Patent GmbH | 5831 |
10 |
| JSR Corporation | 2517 |
8 |
| Royalty Security, LLC | 24 |
7 |
| Ono Pharmaceutical Co., Ltd. | 434 |
6 |
| Janssen Pharmaceutica N.V. | 3392 |
5 |
| Bayer Cropscience AG | 2035 |
5 |
| University of Georgia Research Foundation, Inc. | 1027 |
4 |
| LG Chem, Ltd. | 17632 |
3 |
| National Institute of Advanced Industrial Science and Technology | 3803 |
3 |
| University of Florida Research Foundation, Inc. | 4020 |
3 |
| AAT Bioquest, Inc. | 38 |
3 |
| Hodogaya Chemical Co., Ltd. | 434 |
3 |
| Hong Kong Baptist University | 113 |
3 |
| Infinity Pharmaceuticals, Inc. | 99 |
3 |
| National University Corporation Nagoya University | 856 |
3 |
| Pierre Fabre Medicament | 576 |
3 |
| Other owners | 120 |